Saudi Journal of Gastroenterology

SPECIAL COMMUNICATION
Year
: 2020  |  Volume : 26  |  Issue : 5  |  Page : 233--239

Saudi association for the study of liver diseases and transplantation position statement on liver transplantation during the COVID-19 pandemic


Bandar Al-Judaibi1, Reem Almaghrabi2, Mohammed Alghamdi3, Waleed K Al-Hamoudi4, Mohammed AlQahtani5, Faisal Abaalkhail6, Mohammed Shagrani7, Faisal M Sanai8 
1 Division of Transplant, Department of Surgery, University of Rochester; Division of Gastroenterology, Department of Medicine, University of Rochester, Rochester, New York, United Sates of America
2 Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
3 Department of Medicine, King Fahad Military Medical Complex, Dhahran, Saudi Arabia
4 Department of Medicine, King Saud University, Riyadh, Saudi Arabia
5 Multiorgan Transplant Center, King Fahad Specialist Hospital, Dammam, Saudi Arabia
6 Multiorgan Transplant Center, King Fahad Specialist Hospital, Dammam; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia
7 College of Medicine, Alfaisal University; Liver Transplantation and Organ Transplant Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
8 Gastroenterology Unit, Department of Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia

Correspondence Address:
Dr. Bandar Al-Judaibi
University of Rochester, 500 Joseph C. Wilson Blvd., Rochester, NY - 14627
United Sates of America

The World Health Organization (WHO), on March 11th 2020, upgraded the status of the novel coronavirus disease (COVID-19) from epidemic to pandemic. Over two million individuals have been infected with SARS-CoV-2, the virus causing COVID-19, and as of April, 14th 2020, there were over 5000 confirmed cases in Saudi Arabia (SA). Many countries, including SA, have imposed major restrictions on travel, and everyday life, and the implications of these necessary changes are being felt in liver transplant (LT) centers in SA. Concerns remain that there is an increased risk for individuals over 65 years of age, with underlying medical conditions, or for those who are immunocompromised. Therefore, the Saudi Association for the Study of Liver Diseases and Transplantation (SASLT) established an urgent task force to launch a statement that can be utilized by LT centers as a guidance in the management of patients with advanced liver disease from the time of LT listing to the post-operative care of transplanted patients.


How to cite this article:
Al-Judaibi B, Almaghrabi R, Alghamdi M, Al-Hamoudi WK, AlQahtani M, Abaalkhail F, Shagrani M, Sanai FM. Saudi association for the study of liver diseases and transplantation position statement on liver transplantation during the COVID-19 pandemic.Saudi J Gastroenterol 2020;26:233-239


How to cite this URL:
Al-Judaibi B, Almaghrabi R, Alghamdi M, Al-Hamoudi WK, AlQahtani M, Abaalkhail F, Shagrani M, Sanai FM. Saudi association for the study of liver diseases and transplantation position statement on liver transplantation during the COVID-19 pandemic. Saudi J Gastroenterol [serial online] 2020 [cited 2020 Oct 28 ];26:233-239
Available from: https://www.saudijgastro.com/article.asp?issn=1319-3767;year=2020;volume=26;issue=5;spage=233;epage=239;aulast=Al-Judaibi;type=0